Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
147
-
Total 13F shares, excl. options
-
108M
-
Shares change
-
+20M
-
Total reported value, excl. options
-
$2.34B
-
Value change
-
+$421M
-
Put/Call ratio
-
0.66
-
Number of buys
-
106
-
Number of sells
-
-44
-
Price
-
$21.66
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q1 2023
168 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q1 2023.
Revolution Medicines, Inc. - Common Stock (RVMD) has 147 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 108M shares
of 186M outstanding shares and own 58.17% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (10.4M shares), VANGUARD GROUP INC (9.3M shares), BlackRock Inc. (7.47M shares), EcoR1 Capital, LLC (5.35M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.04M shares), BVF INC/IL (4.96M shares), Nextech Invest Ltd. (4.84M shares), STATE STREET CORP (4.81M shares), Bellevue Group AG (4.75M shares), and Boxer Capital, LLC (4.68M shares).
This table shows the top 147 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.